ストックスクリーナーアプリを入手
64.76
1.41%
0.90
前日終値:
$63.86
開ける：
$64.14
24時間の取引高:
3.91M
Relative Volume:
1.19
時価総額：
$28.84B
収益：
$2.44B
当期純損益:
$1.36B
株価収益率:
33.92
EPS:
1.9093
ネットキャッシュフロー:
$574.14M
1週間 パフォーマンス:
+7.45%
1か月 パフォーマンス:
+11.25%
6か月 パフォーマンス:
+31.15%
1年 パフォーマンス:
+73.81%
1日の値動き範囲:
$64.06
$65.35
1週間の範囲:
$60.78
$65.35
52週間の値動き範囲:
$35.91
$65.35
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, MRNA, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
64.76 | 28.84B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
517.49 | 131.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
807.67 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.85 | 79.39B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
869.33 | 54.67B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
370.87 | 41.95B | 5.76B | 514.49M | 1.10B | 4.4813 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | アップグレード | UBS | Neutral → Buy |
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead - The Motley Fool
Royalty Pharma Announces Fourth-Quarter 2026 Dividend of $0.235 Per Class A Ordinary Share - Quiver Quantitative
Shareholders are set to get 23.5 cents per share from Royalty Pharma on Dec. 10. - Stock Titan
Global femtech market to reach $255.5B by 2035, driven by AI, telehealth, and personalized women's healthcare. - Pluang
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Zacks Investment Research
Form 4 Royalty Pharma Plc For: 12 October By Investing.com - Investing.com India
Royalty Pharma EVP Marshall Urist sells $235,594 in shares - Investing.com
Form 4 Royalty Pharma Plc For: 12 October By Investing.com - Investing.com Nigeria
Royalty Pharma EVP Marshall Urist sells $235,594 in shares By Investing.com - Investing.com Nigeria
Form 4 Royalty Pharma Plc For: 12 October By Investing.com - Investing.com UK
Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again - Zacks Investment Research
At $57.10 a share, Royalty Pharma (RPRX) EVP Marshall Urist sells 4,126 shares. - Stock Titan
Officer Marshall Urist proposes selling 4,126 Royalty Pharma (RPRX) shares. - Stock Titan
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - The Motley Fool
Form 4 Royalty Pharma Plc For: 30 September By Investing.com - Investing.com Nigeria
Form 4 Royalty Pharma Plc For: 30 September By Investing.com - Investing.com South Africa
Royalty Pharma EVP Marshall Urist sells $238,812 in shares - Investing.com
Form 4 Royalty Pharma Plc For: 30 September By Investing.com - Investing.com Canada
Royalty Pharma EVP Marshall Urist sells $238,812 in shares By Investing.com - Investing.com India
Form 4 Royalty Pharma Plc For: 30 September By Investing.com - Investing.com UK
A director acquires 642 shares in lieu of a $37,500 retainer at Royalty Pharma (RPRX). - Stock Titan
4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. - Stock Titan
Form 144 Royalty Pharma plc For: 29 September By Investing.com - Investing.com Nigeria
Form 144 Royalty Pharma plc For: 29 September By Investing.com - Investing.com Canada
Form 144 Royalty Pharma plc For: 29 September By Investing.com - Investing.com South Africa
Form 144 Royalty Pharma plc For: 29 September By Investing.com - Investing.com UK
Royalty Pharma officer proposes $239K share sale | RPRX SEC FilingForm 144 - Stock Titan
Form 144 Royalty Pharma PLC For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com India
Royalty Pharma EVP Christopher Hite sells $5.85m in shares By Investing.com - Investing.com Canada
Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com Nigeria
Royalty Pharma EVP Christopher Hite sells $5.85m in shares - Investing.com
Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com Canada
Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com UK
Royalty Pharma EVP Christopher Hite sells $5.85m in shares By Investing.com - Investing.com UK
Royalty Pharma plc (RPRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Royalty Pharma (RPRX) holder plans new sale after selling 350,000 shares - Stock Titan
Royalty Pharma PLC $RPRX Shares Sold by Corient Private Wealth LP - MarketBeat
Could Royalty Pharma’s (NASDAQ:RPRX) Story Be Changing Fast? - kalkinemedia.com
Royalty Pharma PLC $RPRX Shares Sold by National Pension Service - MarketBeat
Tidal Investments LLC Has $6.63 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
(RPRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
California State Teachers Retirement System Increases Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Strong-Buy - MarketBeat
Engineers Gate Manager LP Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure? - Yahoo Finance
Squarepoint Ops LLC Decreases Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to present at Morgan Stanley global healthcare investor conference - Bitget
Royalty Pharma to present at upcoming investor conferences - marketscreener.com
Royalty Pharma to Present at Upcoming Investor Conferences - Moomoo
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
Royalty Pharma Plc (RPRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Urist Marshall | Officer |
Oct 05 '26 |
Proposed Sale |
57.10 |
4,126 |
235,595 |
0 |
| Urist Marshall | Officer |
Sep 28 '26 |
Proposed Sale |
57.88 |
4,126 |
238,813 |
0 |
| Urist Marshall | EVP, Research & Investments |
Sep 28 '26 |
Sale |
57.88 |
4,126 |
238,813 |
4,126 |
| Hite Christopher | EVP & Chairman, Partnering |
Sep 22 '26 |
Sale |
58.53 |
100,000 |
5,853,095 |
270,401 |
| SCH Investment Partners LLC | Officer |
Sep 22 '26 |
Proposed Sale |
58.47 |
100,000 |
5,846,972 |
0 |
| Hite Christopher | EVP & Chairman, Partnering |
Aug 18 '26 |
Sale |
59.97 |
100,000 |
5,997,250 |
370,401 |
| SCH Investment Partners LLC | Officer |
Aug 18 '26 |
Proposed Sale |
60.12 |
100,000 |
6,012,000 |
0 |
| Coyne Terrance P. | EVP & CFO |
Aug 13 '26 |
Sale |
58.68 |
11,002 |
645,551 |
0 |
| Terrance Coyne | Officer |
Aug 13 '26 |
Proposed Sale |
58.56 |
11,002 |
644,277 |
0 |
| Errol B. De Souza | Former Affiliate |
Aug 12 '26 |
Proposed Sale |
57.79 |
206,352 |
11,925,082 |
0 |
2.04%
1.21%
大文字化:
|
ボリューム (24 時間):